Cinnarizine Capsules

This product is a piperazine calcium channel antagonist, which can prevent pathological calcium influx in smooth muscle cells of vascular walls and relieve vascular spasm. It has the effect of dilating cerebral and peripheral blood vessels, improving cerebral circulation and coronary circulation, especially on cerebral blood vessels. This product can also inhibit phosphodiesterase, prevent cAMP from decomposing into inactive 5-AMP, thereby increasing the concentration of cAMP in cells, inhibiting the release of various biologically active substances such as histamine, 5-hydroxytryptamine, bradykinin, and also inhibiting the activation of complement C4. The lethal dose for humans is 100-500 mg/kg, and the LD50 (oral administration for mice and rats) is greater than 1g/kg.

The main ingredients and chemical names of this product are: 1-diphenylmethyl-4-(3-phenyl-ethyl-propylene)-piperazine

This product is capsule

It is used for the treatment of cerebral thrombosis, cerebral embolism, cerebral arteriosclerosis, cerebral hemorrhage recovery period, subarachnoid hemorrhage recovery period, sequelae of brain trauma, inner ear vertigo, coronary artery sclerosis and diseases caused by poor peripheral circulation. In recent years, relevant literature reports have shown that this product can be used for allergic skin diseases such as chronic urticaria and senile skin itching.

Oral administration, 25-50 mg each time, 3 times a day.

Common symptoms include drowsiness, fatigue, and weight gain in some patients (usually transient). Long-term use may occasionally cause depression and extrapyramidal reactions, such as involuntary movements, rigidity, and dry mouth, muscle pain, and rash in a few patients.

Patients with a history of allergy to this drug or a history of depression are contraindicated using this drug.

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

(1) When used in combination with alcohol, hypnotics or sedatives, the sedative effect is aggravated. (2) When used in combination with phenytoin sodium or carbamazepine, the blood concentration of cinnarizine can be reduced.

Shade, sealed and stored

25mg

24 months

Sinopharm ZHIJUN(Shenzhen)PHARMACEUTICAL Co., Ltd.

• Founded in:

  1985-12-11

• Address:

  No. 16, Lanqing 1st Road, Guanlan High-tech Park, Longhua New District, Shenzhen

• Tax NO.:

  91440300192190290M

• Registered Funds:

  200 million yuan

• Website:

  Log in to view

• Email:

  Log in to view